GlassScriptPhysician profile
Jonathan O Jones
NPI 1518178763
$6,192.69
in general payments reported to CMS, 2019-2025
12 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.53 · 2020: $268 · 2021: $1,195 · 2022: $276 · 2023: $2,005 · 2024: $756 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,429 · Food and Beverage: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,429.03 |
| Food and Beverage | $1,951.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,778.05 | 2019-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $1,665.84 | 2023 | Intracept |
| Si-Bone, INC. | $1,040.57 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $895.50 | 2021-2024 | Zilretta, Iovera, Exparel |
| Boston Scientific Corporation | $632.06 | 2020-2025 | Intracept |
| Nevro Corp. | $68.26 | 2019-2023 | Senza |
| Avanos Medical | $34.87 | 2025 | Generator |
| Depuy Synthes Sales INC. | $18.48 | 2024 | Monovisc, Orthovisc |
| Pacira Therapeutics, INC. | $17.82 | 2019 | |
| Medtronic, INC. | $17.47 | 2023 | Vanta Adaptivestim |
| Allergan, INC. | $12.49 | 2020 | |
| Nalu Medical, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.